{"id":"NCT03605849","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder","officialTitle":"An Open-label, 52-Week, Multicenter Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-02-14","primaryCompletion":"2021-09-07","completion":"2021-09-07","firstPosted":"2018-07-30","resultsPosted":"2024-10-01","lastUpdate":"2024-10-01"},"enrollment":662,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Disorder","Attention Deficit Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Centanafadine SR","otherNames":["EB-1020"]}],"arms":[{"label":"Centanafadine","type":"EXPERIMENTAL"}],"summary":"This study evaluated the long-term safety and tolerability of centanafadine sustained-release (SR) tablets, administered twice daily (BID) in the treatment of adults with attention deficit hyperactivity disorder (ADHD).","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAEs) Graded by Severity","timeFrame":"From first dose of study drug up to 30 days after last dose of study drug (Up to approximately Week 56)","effectByArm":[{"arm":"Prior Centanafadine SR 200 mg","deltaMin":98,"sd":null},{"arm":"Prior Centanafadine SR 400 mg","deltaMin":89,"sd":null},{"arm":"Prior Placebo","deltaMin":123,"sd":null},{"arm":"De Novo Centanafadine SR 400 mg","deltaMin":91,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":154},"commonTop":["Insomnia","Nausea","Diarrhoea","Headache","Decreased Appetite"]}}